Table 1.
Comparison of baseline characteristics, serological parameters, and symptom severities before and 12 weeks after testosterone replacement therapy in both groups
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.